Literature DB >> 12807489

Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis.

Carolin Feterowski1, Klaus Emmanuilidis, Thomas Miethke, Klaus Gerauer, Martina Rump, Kurt Ulm, Bernhard Holzmann, Heike Weighardt.   

Abstract

Genetically determined responsiveness to microbial stimuli such as lipopolysaccharide (LPS) may affect the pathophysiology of human sepsis. The D299G mutation in human Toll-like receptor-4 (TLR4) impairs LPS signalling in homozygous and heterozygous individuals. To investigate whether the presence of the TLR4(D299G) mutation may correlate with the development or outcome of sepsis following major visceral surgery the presence of TLR4(D299G) mutation was analysed in 307 Caucasian patients (154 without and 153 with sepsis). Sepsis was caused in 84% of patients by polymicrobial infection. The presence of the mutant TLR4 did not significantly correlate with development or outcome of sepsis. Serum levels of tumour necrosis factor, interleukin (IL)-10, and IL-6 at sepsis onset did not significantly differ between patients carrying wild-type and mutant TLR4. Moreover, studies in a murine model of polymicrobial septic peritonitis demonstrated that TLR4-deficiency did neither influence the systemic cytokine response nor the development of organ injury. The results suggest that the signalling capacity of TLR4 as affected by loss-of-function mutations does not influence human or experimental sepsis caused by polymicrobial infection. Thus, in polymicrobial infection, other innate immune receptors may compensate for TLR4 defects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807489      PMCID: PMC1782987          DOI: 10.1046/j.1365-2567.2003.01674.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Unresponsiveness of MyD88-deficient mice to endotoxin.

Authors:  T Kawai; O Adachi; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

2.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 3.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 4.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 5.  Sepsis and evolution of the innate immune response.

Authors:  B Beutler; A Poltorak
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 6.  Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned.

Authors:  K Reinhart; W Karzai
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

7.  A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease.

Authors:  R C Read; J Pullin; S Gregory; R Borrow; E B Kaczmarski; F S di Giovine; S K Dower; C Cannings; A G Wilson
Journal:  J Infect Dis       Date:  2001-07-30       Impact factor: 5.226

8.  Massive chemokine transcription in acute renal failure due to polymicrobial sepsis.

Authors:  S Maier; K Emmanuilidis; M Entleutner; N Zantl; M Werner; K Pfeffer; C D Heidecke
Journal:  Shock       Date:  2000-08       Impact factor: 3.454

9.  A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection.

Authors:  E Lorenz; J P Mira; K L Cornish; N C Arbour; D A Schwartz
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

10.  Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4).

Authors:  I Smirnova; A Poltorak; E K Chan; C McBride; B Beutler
Journal:  Genome Biol       Date:  2000-04-27       Impact factor: 13.583

View more
  29 in total

Review 1.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

Review 2.  Modeling sepsis in the laboratory: merging sound science with animal well-being.

Authors:  Jean A Nemzek; Kelly M S Hugunin; Mark R Opp
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

3.  NETWORKS, BIOLOGY AND SYSTEMS ENGINEERING: A CASE STUDY IN INFLAMMATION.

Authors:  P T Foteinou; E Yang; I P Androulakis
Journal:  Comput Chem Eng       Date:  2009-12-10       Impact factor: 3.845

Review 4.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

Review 5.  Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Arshad
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

Review 6.  Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases.

Authors:  C Skevaki; M Pararas; K Kostelidou; A Tsakris; J G Routsias
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

7.  Lack of Toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia.

Authors:  Hee Jung Yoon; Jun Yong Choi; Chang Oh Kim; Yoon Seon Park; Myoung Soo Kim; Young Keun Kim; So Youn Shin; June Myung Kim; Young Goo Song
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

8.  The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies.

Authors:  Peter Weyrich; Harald Staiger; Alena Stančáková; Fausto Machicao; Jürgen Machann; Fritz Schick; Norbert Stefan; Johanna Kuusisto; Markku Laakso; Silke Schäfer; Andreas Fritsche; Hans-Ulrich Häring
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

Review 9.  Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Authors:  Andrei E Medvedev
Journal:  J Interferon Cytokine Res       Date:  2013-05-15       Impact factor: 2.607

Review 10.  Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?

Authors:  Birgit Terjung; Ulrich Spengler
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.